HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aging macular degeneration. Clinical features of treatable disease.

Abstract
Argon laser treatment reduces visual loss in patients with aged macular degeneration and extrafoveal subretinal neovascular membranes (SRNVM). Ophthalmologists must now educate patients concerning the symptoms of subretinal neovascularization and give them an Amsler grid. If a patient develops symptoms he should be examined promptly. High quality fluorescein angiograms and meticulous contact lens examinations of the macula should be performed to detect subtle neovascularization. Ophthalmologists must be familiar with the clinical and fluorescein angiographic changes of drusen, retinal pigment epithelial atrophy, and retinal pigment epithelial detachments in order to differentiate them from subretinal neovascular membranes.
AuthorsJ C Folk
JournalOphthalmology (Ophthalmology) Vol. 92 Issue 5 Pg. 594-602 (May 1985) ISSN: 0161-6420 [Print] United States
PMID2409501 (Publication Type: Journal Article)
Topics
  • Aged
  • Fluorescein Angiography
  • Humans
  • Laser Therapy
  • Macular Degeneration (complications, diagnosis, pathology, surgery)
  • Neovascularization, Pathologic (etiology)
  • Retina (blood supply)
  • Retinal Hemorrhage (etiology)
  • Vision Disorders (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: